-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Pelthos Therapeutics Inc. quarterly/annual Operating Income (Loss) history and change rate from 2022 to Q3 2025.
- Pelthos Therapeutics Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$15.4M, a 650% decline year-over-year.
- Pelthos Therapeutics Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$22.3M, a 131% decline year-over-year.
- Pelthos Therapeutics Inc. annual Operating Income (Loss) for 2024 was -$7.57M, a 10.3% decline from 2023.
- Pelthos Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$6.86M, a 196% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)